How the unfolding of notable infringement claim could alter commercial approaches for players in wider CBD treatment field.
David Knight
Advertisement
Articles by David Knight
Advertisement
Latest Updated Articles
Commercializing Cannabis and Patent LitigationPublished: February 10th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
3
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
4
Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model
5